PBS Website Update - 1 April 2024
Page last updated: 1 April 2024
The Schedule of Pharmaceutical Benefits was updated on 1 April 2024. New, Amended and Deleted items can be found on the Summary of Changes page.
The following updates have also been made to the PBS Website on the dates specified.
- PBS Continued Dispensing Arrangements - 1 April 2024
- PBS Arrangements to Support Australians Affected by Natural Disasters and Emergencies - 1 April 2024
- 1 April 2024 designated brand list – minimum stockholding requirements - 1 April 2024
- Medicine Status Website - 1 April 2024
- Ex-manufacturer price - 1 April 2024
- Formulary Allocations - 1 April 2024
- First New Brand Price Reductions - 1 April 2024
- Section 19A medicines subsidised by the Pharmaceutical Benefits Scheme - 1 April 2024
- Current Price Disclosure cycle – 2024 April - 28 March 2024
- Stocktake of PBS medicines available for endometriosis and related conditions Report - 28 March 2024
- Updates to the HTA Policy and Methods Review Reference Committee – 26 March 2024
- Drug Utilisation Sub-Committee (DUSC) Utilisation Analysis Public Release Documents - 22 March 2024
- Drug Utilisation Sub-Committee (DUSC) Outcome Statement - 22 March 2024
- PBAC Chair and MSAC Chair and Deputy Chairs EOI outcome - 22 March 2024
- Consultation Open: Co-design of an Enhanced Consumer Engagement Process - 18 March 2024
- PBS and RPBS Section 85 Date of Supply Data - 13 March 2024
- Updates to the HTA Policy and Methods Review Reference Committee – 8 March 2024
- Updated Agenda for March 2024 PBAC Meeting – 6 March 2024
- Pharmaceutical Reform Agreement (PRA) Review Report - 6 March 2024
- PBAC Public Summary Documents – November 2023 meeting - 1 March 2024
- PBS arrangements due to discontinuation of Ordine 10 (morphine hydrochloride trihydrate) oral liquids effective 1 March 2024 - 1 March 2024
- Nurse practitioner and endorsed midwife prescribing: consultation survey live - 1 March 2024
